According to results obtained by Torres et al., BRCA1 and BRCA2 gene mutations have been found affecting between 5 and 8% of breast cancer Colombian patients, and 10% of patients with ovarian cancer 6-.8 This evidence concerns the gene BRCA1 and breast cancer.